A Prospective Randomized Phase III Trial of Maintenance Pemetrexed Versus Observation in Patients With Recurrent or Metastatic Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Without Disease Progression
Latest Information Update: 05 Mar 2024
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin; Cisplatin; Dexamethasone; Folic acid; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms PREMIER
- 27 Jan 2024 Status changed from recruiting to discontinued.
- 27 Jan 2024 Results ( from Oct 2016 to Dec 2022, n=97) assessing safety and efficacy of Pemetrexed maintenance versus observation in patients with advanced urothelial carcinoma presented at the 2024 Genitourinary Cancers Symposium
- 23 Jun 2017 New trial record